December 14, 2017
- Drug Approval Package: Bortezomib Injection
- Drug Firm Annual Registration Status (updated)
- FDA Drug Shortages
- Memantine Hydrochloride (NAMENDA) Oral Solution (New - Discontinuation)
- FDA Statement: FDA reminds pharmaceutical industry of new drug listing certification requirement due December 31, 2017
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- Electronic Registration and Listing Compliance Program (updated)
- Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations (updated)
- Pediatric Exclusivity Granted (updated)
- REMS Integration Initiative (updated)
.png)
No hay comentarios:
Publicar un comentario